Informations sur le produit
- benzamide, 2,6-dichloro-N-(1-cyanocycloheptyl)-
- 2,6-Dichlor-N-(1-cyancycloheptyl)benzamid
2,6-Dichloro-N-(1-cyanocycloheptyl)benzamide (2,6-DCB) is a monoclonal antibody that binds to the CD20 antigen on B cells and inhibits the production of autoantibodies. This drug has been shown to be more potent than other anti-CD20 antibodies in clinical studies involving animals with autoimmune diseases. 2,6-DCB could potentially be used as a biomarker for autoimmune diseases because it may bind to proteins produced by necrotic cells. In women, chronic kidney disease (CKD) is associated with increased levels of serum autoantibodies and an increased risk of CKD progression. A mouse strain with genetic deletion of CD20 and two strains with single gene mutations in CD20 were used to study the effects of 2,6-DCB on autoimmunity. These studies showed that 2,6-DCB can inhibit autoimmunity
Propriétés chimiques
Question d’ordre technique sur : 3D-MLB76362 2,6-Dichloro-N-(1-cyanocycloheptyl)benzamide
Si vous souhaitez demander un devis ou passer commande, veuillez plutôt ajouter les produits souhaités à votre panier, puis demander un devis ou passer commande à partir de votre panier. C'est une méthode plus rapide, plus économique, et vous pourrez bénéficier des remises disponibles ainsi que d'autres avantages
